Featuring Licensed Content from ASCO: New Advances in Lung Cancer
Sales end soon

Featuring Licensed Content from ASCO: New Advances in Lung Cancer

Featuring Licensed Content from ASCO

By eChinaHealth, Inc.

Date and time

Saturday, May 31 · 4:30 - 5:30pm PDT

Location

Online

Agenda

Opening Remark

Dr. Jonathan Cheng, SystImmune, Inc.

Moderator

Keynote Presentation

Dr. Yunpeng Yang, Sun Yat-Sen University Cancer Center

Abstract 3001: Phase 1 study of iza-bren (BL-B01D1), an EGFR x HER3 bispecific antibody-drug conjugate (ADC) in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with dr...

Panel Discussion

- Dr. Giorgia Vicentini, VP, Global Program Lead Bristol Myers Squibb - Dr. Yunpeng Yang, Sun Yat-Sen University Cancer Center - Dr. Yan Huang, Sun Yat-Sen University Cancer Center - Dr. Patrick Ford...

Closing Remark

Dr. Jonathan Cheng, SystImmune, Inc.

About this event

  • Event lasts 1 hour

Date/Time:


  • Central Standard Time: 06:30 p.m., May 31st, 2025
  • Beijing Time: 07:30 a.m., June 1st, 2025


Language:

  • English, with Chinese Simultaneous Translation


Venue:

  • Zoom Webinar

Tags

Organized by

eChinaHealth, Inc.

eChinaHealth is an integrated media for China healthcare and pharmaceutical segments. eChinaHealth services include digital platform and media, conferences and events, data and consulting, and social network and community.

Free